Discontinuation of renal replacement therapy in critically ill patients with severe acute kidney injury: predictive factors of renal function recovery
- PMID: 30073616
- DOI: 10.1007/s11255-018-1947-1
Discontinuation of renal replacement therapy in critically ill patients with severe acute kidney injury: predictive factors of renal function recovery
Abstract
Introduction: Severe acute kidney injury (AKI-D) is common in critically ill patients and contributes substantially to short- and long-term morbidity and mortality. Acute renal replacement therapy (RRT) is an increasingly widely utilized life-sustaining support strategy for AKI-D patients, providing a bridge to renal recovery in many survivors of AKI. However, key aspects (when and how) of this therapy's appropriate cessation remain unclear. Today, wide variation in clinical practice exists regarding the indication for and the timing of RTT discontinuation, likely due to the poor current evidence base.
Methods: Few studies have evaluated the process of weaning or ideal markers (clinical factors or parameters that may suggest renal recovery, such as urine output, urine chemistry, and creatinine clearance) to predict sufficient recovery of renal function following AKI and to avoid re-institution of RRT. However, translation of the current evidence to clinical practice is hampered by considerable limitations of the retrospective, post hoc secondary design of cohort studies, small sample sizes, heterogeneity across study populations and illness severity, variations of the thresholds of predictive markers and conflicting results for given markers. Currently, 24-h creatinine clearance greater than 20 ml/min combined with spontaneously decreasing serum creatinine concentrations in the context of fixed RRT and a clinically stable intensive care unit (ICU) patient may be the best predictor of recovery of excretory renal function.
Conclusion: The decision regarding the appropriate time to wean acute RRT is complex, integrating numerous clinical variables and renal functional parameters. Cessation of RRT should largely be individualized in critically ill patients. Large randomized multicentre trials are needed to definitively answer the vitally important question of whether inappropriate discontinuation of RRT in ICU patients with AKI-D impacts patient outcomes. Future work should integrate novel kidney damage and repair biomarkers and techniques to measure real-time glomerular filtration rates.
Keywords: Acute kidney injury; Discontinuation of renal replacement therapy.
Similar articles
-
Determining the optimal time for liberation from renal replacement therapy in critically ill patients: a systematic review and meta-analysis (DOnE RRT).Crit Care. 2020 Feb 13;24(1):50. doi: 10.1186/s13054-020-2751-8. Crit Care. 2020. PMID: 32054522 Free PMC article.
-
Effects of renal replacement therapy on renal recovery after acute kidney injury.Nephron Clin Pract. 2014;127(1-4):35-41. doi: 10.1159/000363671. Epub 2014 Sep 24. Nephron Clin Pract. 2014. PMID: 25343818 Review.
-
Biomarkers upon discontinuation of renal replacement therapy predict 60-day survival and renal recovery in critically ill patients with acute kidney injury.Hemodial Int. 2018 Jan;22(1):56-65. doi: 10.1111/hdi.12532. Epub 2017 Jan 11. Hemodial Int. 2018. PMID: 28078828
-
Current Approach to Successful Liberation from Renal Replacement Therapy in Critically Ill Patients with Severe Acute Kidney Injury: The Quest for Biomarkers Continues.Mol Diagn Ther. 2021 Jan;25(1):1-8. doi: 10.1007/s40291-020-00498-z. Epub 2020 Oct 24. Mol Diagn Ther. 2021. PMID: 33099671 Free PMC article. Review.
-
When to stop renal replacement therapy in anticipation of renal recovery in AKI: The need for consensus guidelines.Semin Dial. 2019 May;32(3):205-209. doi: 10.1111/sdi.12773. Epub 2019 Jan 28. Semin Dial. 2019. PMID: 30690779
Cited by
-
Association between furosemide administration and clinical outcomes in patients with sepsis-associated acute kidney injury receiving renal replacement therapy: a retrospective observational cohort study based on MIMIC-IV database.BMJ Open. 2023 Jul 30;13(7):e074046. doi: 10.1136/bmjopen-2023-074046. BMJ Open. 2023. PMID: 37518073 Free PMC article.
-
Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials.Crit Care. 2023 Jun 7;27(1):222. doi: 10.1186/s13054-023-04519-1. Crit Care. 2023. PMID: 37287084 Free PMC article.
-
Incidence- and In-hospital Mortality-Related Risk Factors of Acute Kidney Injury Requiring Continuous Renal Replacement Therapy in Patients Undergoing Surgery for Acute Type a Aortic Dissection.Front Cardiovasc Med. 2021 Nov 23;8:749592. doi: 10.3389/fcvm.2021.749592. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34888362 Free PMC article.
-
miR‑30a‑5p inhibits hypoxia/reoxygenation‑induced oxidative stress and apoptosis in HK‑2 renal tubular epithelial cells by targeting glutamate dehydrogenase 1 (GLUD1).Oncol Rep. 2020 Oct;44(4):1539-1549. doi: 10.3892/or.2020.7718. Epub 2020 Aug 7. Oncol Rep. 2020. PMID: 32945480 Free PMC article.
-
Association between regional economic status and renal recovery of dialysis-requiring acute kidney injury among critically ill patients.Sci Rep. 2020 Sep 3;10(1):14573. doi: 10.1038/s41598-020-71540-7. Sci Rep. 2020. PMID: 32884077 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
